Publications by authors named "Manik Chatterjee"

Claim this Profile
[
[CAR T cell therapy in acute lymphoblastic leukemia].
Manik Chatterjee, Ralf C Bargou

Inn Med (Heidelb)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Baseline β-Catenin Comutations on Prognosis in EGFR-Mutant Lung Cancer.
Jonas Kulhavy, Katja Maurus, Miriam Blasi, Stephanie Brändlein, Simone Reu-Hofer, Manik Chatterjee

JCO Precis Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous T cell therapy for PRAME advanced solid tumors in HLA-A*02 patients: a phase 1 trial.
Martin Wermke, Dejka M Araujo, Manik Chatterjee, Apostolia M Tsimberidou, Tobias A W Holderried

Nat Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Autologous T cell therapy for PRAME advanced solid tumors in HLA-A*02 patients: a phase 1 trial.
Martin Wermke, Dejka M Araujo, Manik Chatterjee, Apostolia M Tsimberidou, Tobias A W Holderried

Nat Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany.
Markus Krebs, Florian Haller, Silvia Spörl, Elena Gerhard-Hartmann, Kirsten Utpatel, Manik Chatterjee

Eur J Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid response to selpercatinib in RET fusion positive pancreatic neuroendocrine carcinoma confirmed by smartwatch.
Barbara Deschler-Baier, Markus Krebs, Matthias Kroiss, Manik Chatterjee, Daniel Gundel

NPJ Precis Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cynaropicrin disrupts tubulin and c-Myc-related signaling and induces parthanatos-type cell death in multiple myeloma.
Joelle C Boulos, Ejlal A Omer, Daniela Rigano, Carmen Formisano, Manik Chatterjee

Acta Pharmacol Sin· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia.
Joelle C Boulos, Manik Chatterjee, Letian Shan, Thomas Efferth

Cancers (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ancistrocladinium A Induces Apoptosis in Proteasome Inhibitor-Resistant Multiple Myeloma Cells: A Promising Therapeutic Agent Candidate.
Daniela Brünnert, Raina Seupel, Pankaj Goyal, Matthias Bach, Heike Schraud, Manik Chatterjee

Pharmaceuticals (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New forms of immunotherapy in uro-oncology : HLA-independent therapeutic approaches with bispecific antibodies and CAR T cells].
Markus Krebs, Manik Chatterjee, Hubert Kübler, Charis Kalogirou

Urologie· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma.
Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M Poos, Britta Besemer

Blood· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of Lipid Raft Microdomains, Regulation of CD38, TP53, and MYC Signaling, and Induction of Apoptosis by Lomitapide in Multiple Myeloma Cells.
Mohamed E M Saeed, Joelle C Boulos, Sabrina B Mücklich, Ellen Leich, Manik Chatterjee

Cancer Genomics Proteomics· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia.
Eytan M Stein, Daniel J DeAngelo, Jörg Chromik, Manik Chatterjee, Sebastian Bauer

Clin Cancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cereblon enhancer methylation and IMiD resistance in multiple myeloma.
Larissa Haertle, Santiago Barrio, Umair Munawar, Seungbin Han, Xiang Zhou, Manik Chatterjee

Blood· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells.
Joelle C Boulos, Mohamed E M Saeed, Manik Chatterjee, Yagmur Bülbül, Francesco Crudo

Pharmaceuticals (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma.
Matteo C Da Vià, Oliver Dietrich, Marietta Truger, Panagiota Arampatzi, Johannes Duell, Manik Chatterjee

Nat Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma.
Ellen Leich, Martin Schreder, Jordan Pischimarov, Thorsten Stühmer, Torsten Steinbrunn, Manik Chatterjee

Blood Cancer J· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pasotuxizumab, a BiTE immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings.
Horst-Dieter Hummel, Peter Kufer, Carsten Grüllich, Ruth Seggewiss-Bernhardt, Barbara Deschler-Baier, Manik Chatterjee

Immunotherapy· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models.
Viktoria Kunz, Kathryn S Bommert, Jessica Kruk, Daniel Schwinning, Manik Chatterjee

Sci Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS.
Marcel Seibold, Thorsten Stühmer, Nadine Kremer, Anja Mottok, Claus-Jürgen Scholz, Manik Chatterjee

Haematologica· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial.
Marc S Raab, Monika Engelhardt, Antje Blank, Hartmut Goldschmidt, Hermine Agis, Manik Chatterjee

Lancet Haematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90β and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth.
Daniela Brünnert, Clara Langer, Luise Zimmermann, Ralf C Bargou, Martin Burchardt, Manik Chatterjee

J Cell Biochem· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab.
Vera Dufner, Cyrus M Sayehli, Manik Chatterjee, Horst D Hummel, Götz Gelbrich

Blood Adv· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma.
Daniela Brünnert, Marianne Kraus, Thorsten Stühmer, Stefanie Kirner, Robin Heiden, Manik Chatterjee

Biochim Biophys Acta Mol Basis Dis· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum and functional validation of PSMB5 mutations in multiple myeloma.
Santiago Barrio, Thorsten Stühmer, Matteo Da-Viá, Clara Barrio-Garcia, Nicola Lehners, Manik Chatterjee

Leukemia· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis